Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"PloS one"
NOT title:"systemat review"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22PloS+one%22&filter%5B%5D=NOT+title%3Asystemat+review&lookfor=%22Antibodies%2C+Monoclonal%2C+Humanized%22&type=Subject
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22PloS+one%22&filter%5B%5D=NOT+title%3Asystemat+review&lookfor=%22Antibodies%2C+Monoclonal%2C+Humanized%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22PloS+one%22&filter%5B%5D=NOT+title%3Asystemat+review&lookfor=%22Antibodies%2C+Monoclonal%2C+Humanized%22&type=Subject
PubPharm (387)
1
Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion : A case study for pembrolizumab and daratumumab
enthalten in:
PloS one
| 2024
von
Heine, R.
|
Thielen, F.
|
Mathijssen, R.
| +3
Wird geladen...
2
Cost-utility analysis of atezolizumab combined with bevacizumab for unresectable hepatocellular carcinoma in Thailand
enthalten in:
PloS one
| 2024
von
Sriphoosanaphan, S.
|
Pantumongkol, W.
|
Kulpeng, W.
| +5
Wird geladen...
3
Visual outcomes of intraocular inflammation after brolucizumab injection in Japanese patients with neovascular age-related macular degeneration
enthalten in:
PloS one
| 2024
von
Hirono, K.
|
Maruyama-Inoue, M.
|
Yanagi, Y.
| +1
Wird geladen...
4
Cost-effectiveness of one-year adjuvant trastuzumab therapy in treatment for early-stage breast cancer patients with HER2+ in Vietnam
enthalten in:
PloS one
| 2024
von
Nguyen, A.
|
Tran, O.
|
Nguyen, P.
| +1
Wird geladen...
5
Cost-effectiveness analysis of Tislelizumab vs Sorafenib as the first-line treatment of unresectable hepatocellular carcinoma
enthalten in:
PloS one
| 2024
von
Chen, Q.
|
Sun, Q.
|
Zhang, J.
| +3
Wird geladen...
6
Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma : A multicenter prospective observational study
enthalten in:
PloS one
| 2024
von
Kai, M.
|
Hikita, H.
|
Kazuki, M.
| +25
Wird geladen...
7
Confocal laser endomicroscopy as predictive biomarker of clinical and endoscopic efficacy of vedolizumab in ulcerative colitis : The DETECT study
enthalten in:
PloS one
| 2024
von
Quénéhervé, L.
|
Trang-Poisson, C.
|
Fantou, A.
| +14
Wird geladen...
8
Brolucizumab in recalcitrant neovascular age-related macular degeneration-real-world data in Chinese population
enthalten in:
PloS one
| 2024
von
Weng, C.
|
Chi, S.
|
Lin, T.
| +4
Wird geladen...
9
Usefulness of atezolizumab plus bevacizumab as second-line therapy for patients with unresectable hepatocellular carcinoma
enthalten in:
PloS one
| 2024
von
Yamaba, S.
|
Imai, Y.
|
Sugawara, K.
| +5
Wird geladen...
10
Respiratory syncytial virus reinfections among infants and young children in the United States, 2011-2019
enthalten in:
PloS one
| 2023
von
Nduaguba, S.
|
Tran, P.
|
Choi, Y.
| +1
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[39]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Filter aufheben
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: PloS one
Medienart
387
Aufsätze
387
E-Artikel
387
E-Ressourcen
Zeitschriftentitel
PloS one
Thema
387
Antibodies, Monoclonal, Humanized
387
Journal Article
258
Research Support, Non-U.S. Gov't
101
Antibodies, Monoclonal
93
EC 2.7.10.1
70
Antineoplastic Agents
60
2S9ZZM9Q9V
60
Bevacizumab
51
P188ANX8CK
51
Research Support, N.I.H., Extramural
51
Trastuzumab
47
Receptor, ErbB-2
40
Cetuximab
40
PQX0D8J21J
32
Angiogenesis Inhibitors
31
I031V2H011
31
tocilizumab
30
ErbB Receptors
30
Vascular Endothelial Growth Factor A
24
Randomized Controlled Trial
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
79
2020-
297
2010-2019
11
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
387
Englisch
Haven't found what you're looking for?
Wird geladen...